AlloDerm implants for prevention of Frey syndrome after parotidectomy: A systematic review and meta-analysis

Molecular Medicine Reports

Volumn 5, Issue 4, 2012, Pages 974-980

  Zeng, Xian Tao ^a   Tang, Xiang Jun ^a   Wang, Xue Jun ^a   Li, Miao Zhu ^b   Guo, Yi ^c   Huang, Wei ^a   Niu, Yu Ming ^a   Leng, Wei Dong ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

AlloDerm; Frey syndrome; Meta analyses; Parotidectomy; Saliva fistula; Systematic review

Indexed keywords

CLINICAL EFFECTIVENESS; FACIAL NERVE PARALYSIS; FISTULA; FREY SYNDROME; HUMAN; IMPLANT; INCIDENCE; PAROTIDECTOMY; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; RISK REDUCTION; SALIVARY FISTULA; SEROMA; SYSTEMATIC REVIEW;

COLLAGEN; HUMANS; PAROTID GLAND; PROSTHESES AND IMPLANTS; SWEATING, GUSTATORY;

FISTULA;

EID: 84863267789     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.762     Document Type: Review

References (55)

1. Ansari MH: Salivary gland tumors in an Iranian population: a retrospective study of 130 cases. J Oral Maxillofac Surg 65: 2187-2194, 2007.
2. Vuhahula EA: Salivary gland tumors in Uganda: clinical pathological study. Afr Health Sci 4: 15-23, 2004.
3. Pinkston JA and Cole P: Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 120: 834-840, 1999. (Pubitemid 29269715)
4. Li LJ, Li Y, Wen YM, Liu H and Zhao HW: Clinical analysis of salivary gland tumor cases in West China in the past 50 years. Oral Oncol 44: 187-192, 2008. (Pubitemid 351179663)
5. Smiddy FG: Treatment of mixed parotid tumours. Br Med J 1: 322-325, 1956.
6. Lim YC, Lee SY, Kim K, et al: Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol 41: 1021-1027, 2005. (Pubitemid 41434068)
7. Clayman MA, Clayman SM and Seagle MB: A review of the surgical and medical treatment of Frey syndrome. Ann Plast Surg 57: 581-584, 2006. (Pubitemid 44632165)
8. Herxheimer A: Gustatory sweating and pilomotion. Br Med J 1: 688-689, 1958.
9. Patey DH: Risk of facial paralysis after parotidectomy. Br Med J 2: 1100-1102, 1963.
10. Mohyuddin N, Hoff SR and Yao M: The use of allograft dermis implants and the facelift incision in parotid surgery. Operative Techniques in Otolaryngology-Head and Neck Surgery 20: 114-119, 2009.
11. Nitzan D, Kronenberg J, Horowitz Z, et al: Quality of life following parotidectomy for malignant and benign disease. Plast Reconstr Surg 114: 1060-1067, 2004. (Pubitemid 40362024)
12. Koch M, Zenk J and Iro H: Long-term results of morbidity after parotid gland surgery in benign disease. Laryngoscope 120: 724-730, 2010.
13. Harrison K and Donaldson I: Frey's syndrome. J R Soc Med 72: 503-508, 1979. (Pubitemid 10219625)
14. De Bree R, van der Waal I and Leemans CR: Management of Frey syndrome. Head Neck 29: 773-778, 2007. (Pubitemid 47265533)
15. Dulguerov P, Marchal F and Gysin C: Frey syndrome before Frey: the correct history. Laryngoscope 109: 1471-1473, 1999. (Pubitemid 29426543)
16. Dulguerov P, Marchal F and Gysin C: The bullet that hit a nerve: the history of Lucja Frey and her syndrome. J Laryngol Otol 120: 1087, 2006. (Pubitemid 46132601)
17. Glaister DH, Hearnshaw JR, Heffron PF, Peck AW and Patey DH: The mechanism of post-parotidectomy gustatory sweating (the auriculo-temporal syndrome). Br Med J 2: 942-946, 1958.
18. Baek CH, Chung MK, Jeong HS, et al: Questionnaire evaluation of sequelae over 5 years after parotidectomy for benign diseases. J Plast Reconstr Aesthet Surg 62: 633-638, 2009.
19. Beutner D, Wittekindt C, Dinh S, Huttenbrink KB and Guntinas-Lichius O: Impact of lateral parotidectomy for benign tumors on quality of life. Acta Otolaryngol 126: 1091-1095, 2006.
20. Bomeli SR, Desai SC, Johnson JT and Walvekar RR: Management of salivary flow in head and neck cancer patients - a systematic review. Oral Oncol 44: 1000-1008, 2008.
21. Wang CC and Wang CP: Preliminary experience with botulinum toxin type A intracutaneous injection for Frey's syndrome. J Chin Med Assoc 68: 463-467, 2005.
22. Asal K, Koybasioglu A, Inal E, et al: Sternocleidomastoid muscle flap reconstruction during parotidectomy to prevent Frey's syndrome and facial contour deformity. Ear Nose Throat J 84: 173-176, 2005. (Pubitemid 43093479)
23. Rubinstein RY, Rosen A and Leeman D: Frey syndrome: treatment with temporoparietal fascia flap interposition. Arch Otolaryngol Head Neck Surg 125: 808-811, 1999. (Pubitemid 29323926)
24. Moulton-Barrett R, Allison G and Rappaport I: Variation's in the use of SMAS (superficial musculoaponeurotic system) to prevent Frey's syndrome after parotidectomy. Int Surg 81: 174-176, 1996.
25. Wallis KA and Gibson T: Gustatory sweating following parotidectomy: correction by a fascia lata graft. Br J Plast Surg 31: 68-71, 1978. (Pubitemid 8263939)
26. Chandarana S, Fung K, Franklin JH, Kotylak T, Matic DB and Yoo J: Effect of autologous platelet adhesives on dermal fat graft resorption following reconstruction of a superficial parotidectomy defect: a double-blinded prospective trial. Head Neck 31: 521-530, 2009.
27. Shemen LJ: Expanded polytef for reconstructing postparotidectomy defects and preventing Frey's syndrome. Arch Otolaryngol Head Neck Surg 121: 1307-1309, 1995.
28. Guntinas-Lichius O, Gabriel B and Klussmann JP: Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Acta Otolaryngol 126: 1104-1109, 2006. (Pubitemid 44272838)
29. Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Marchal F and Lehmann W: Prevention of Frey syndrome during parotidectomy. Arch Otolaryngol Head Neck Surg 125: 833-839, 1999. (Pubitemid 29372801)
30. Achauer BM, Van der Kam VM, Celikoz B and Jacobson DG: Augmentation of facial soft-tissue defects with Alloderm dermal graft. Ann Plast Surg 41: 503-507, 1998. (Pubitemid 28511793)
31. Shulman J: Clinical evaluation of an acellular dermal allograft for increasing the zone of attached gingiva. Pract Periodontics Aesthet Dent 8: 201-208, 1996.
32. Thoma DS, Benic GI, Zwahlen M, Hammerle CH and Jung RE: A systematic review assessing soft tissue augmentation techniques. Clin Oral Implants Res 20 (Suppl 4): 146-165, 2009.
33. Webster K: Early results using a porcine dermal collagen implant as an interpositional barrier to prevent recurrent Frey's syndrome. Br J Oral Maxillofac Surg 35: 104-106, 1997.
34. Govindaraj S, Cohen M, Genden EM, Costantino PD and Urken ML: The use of acellular dermis in the prevention of Frey's syndrome. Laryngoscope 111: 1993-1998, 2001. (Pubitemid 33042117)
35. Li DZ, Wu YH, Wang XL, Liu SY and Li ZJ: [Prospective cohort study on prevention of Frey syndrome in parotid surgery]. Zhonghua Wai Ke Za Zhi 44: 1033-1035, 2006.
36. Sinha UK, Saadat D, Doherty CM and Rice DH: Use of AlloDerm implant to prevent Frey syndrome after parotidectomy. Arch Facial Plast Surg 5: 109-112, 2003.
37. Ye WM, Zhu HG, Zheng JW, et al: Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy. Br J Oral Maxillofac Surg 46: 649-652, 2008.
38. Yu K, Yang J, Li MJ and Ma HB: [Clinical application of acellular dermal matrix to prevent gustatory sweating syndrome]. Zhonghua Kou Qiang Yi Xue Za Zhi 42: 570-571, 2007.
39. Chen W, Li J, Yang Z, Yongjie W, Zhiquan W and Wang Y: SMAS fold flap and ADM repair of the parotid bed following removal of parotid haemangiomas via pre- and retroauricular incisions to improve cosmetic outcome and prevent Frey's syndrome. J Plast Reconstr Aesthet Surg 61: 894-900, 2008.
40. Clayman MA and Clayman LZ: Use of AlloDerm as a barrier to treat chronic Frey's syndrome. Otolaryngol Head Neck Surg 124: 687, 2001. (Pubitemid 33586473)
41. Papadogeorgakis N, Petsinis V, Christopoulos P, Mavrovouniotis N and Alexandridis C: Use of a porcine dermal collagen graft (Permacol) in parotid surgery. Br J Oral Maxillofac Surg 47: 378-381, 2009.
42. Higgins JPT and Green S (eds.): Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
43. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12, 1996. (Pubitemid 26120810)
44. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002. (Pubitemid 34746062)
45. Egger M and Smith GD: Bias in location and selection of studies. BMJ 316: 61-66, 1998.
46. MacKinnon C and Lovie M: An alternative treatment for Frey syndrome. Plast Reconstr Surg 103: 745-746, 1999.
47. Curry JM, King N, Reiter D, Fisher K, Heffelfinger RN and Pribitkin EA: Meta-analysis of surgical techniques for preventing parotidectomy sequelae. Arch Facial Plast Surg 11: 327-331, 2009.
48. Sachsman SM and Rice DH: Use of AlloDerm implant to improve cosmesis after parotidectomy. Ear Nose Throat J 86: 512-513, 2007. (Pubitemid 351268070)
49. Lopez Gutierrez JC: The SMAS fold flap and ADM repair of the parotid bed following removal of parotid haemangiomas via pre- and retroauricular incisions to improve cosmetic outcome and prevent Frey's syndrome. J Plast Reconstr Aesthet Surg 61: 900, 2008.
50. Wu JK: The SMAS fold flap and ADM repair of the parotid bed following removal of parotid haemangiomas via pre- and retroauricular incisions to improve cosmetic outcome and prevent Frey's syndrome. J Plast Reconstr Aesthet Surg 21: 889-900, 2008.
51. Rustemeyer J, Eufinger H and Bremerich A: The incidence of Frey's syndrome. J Craniomaxillofac Surg 36: 34-37, 2008.
52. Malatskey S, Rabinovich I, Fradis M and Peled M: Frey syndrome - delayed clinical onset: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94: 338-340, 2002. (Pubitemid 41124770)
53. Wenzel GI and Draf W: Unusually long latency before the appearance of Frey's syndrome after parotidectomy. HNO 52: 554-556, 2004 (In German). (Pubitemid 38843191)
54. Shuman AG and Bradford CR: Ethics of Frey syndrome: ensuring that consent is truly informed. Head Neck 32: 1125-1128, 2010.
55. Schulz KF, Altman DG, Moher D and Group C: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340: c332, 2010.